- Home
- / Clasp Therapeutics
Clasp Therapeutics
Total Funding
$150 M
Clasp Therapeutics Summary
Company Summary
- Overview
- Clasp Therapeutics is a company that provides immuno-oncology solutions. It develops T cell engagers (TCEs) that enable the immune system to identify and destroy tumor cells.
- Type
- Private
- Status
- Active
- Founded
- 2020
- HQ
- Rockville, MD, US | view all locations
- Website
- https://www.clasptx.com
- Sectors
Table of Contents
Key People
Andrea van Elsas, Interim Chief Scientific Officer, Director
James B. Bingham, Chief Technology Officer
Caren Block, Chief People Officer
LocationsView all
2 locations detected
Rockville, MD HQ
United States
1450 Research Blvd., Suite 120
Cambridge, MA
United States
One Kendall Square